117 related articles for article (PubMed ID: 7865238)
21. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
22. [A clinical study of the non-Hodgkin's lymphomas according to the Kiel classification (author's transl)].
Stacher A; Heinz R; Waldner R
Arch Geschwulstforsch; 1979; 49(8):715-30. PubMed ID: 120730
[TBL] [Abstract][Full Text] [Related]
23. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
[TBL] [Abstract][Full Text] [Related]
24. [Effect of PD-1, FOXP3 and CSF-1R Protein Expression on the Prognosis of Patients with Hodgkin's Lymphoma].
Li XJ; He L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Oct; 26(5):1372-1377. PubMed ID: 30295253
[TBL] [Abstract][Full Text] [Related]
25. MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Sertoli MR; Santini G; Chisesi T; Congiu AM; Rubagotti A; Contu A; Salvagno L; Coser P; Porcellini A; Vespignani M
J Clin Oncol; 1994 Jul; 12(7):1366-74. PubMed ID: 7517442
[TBL] [Abstract][Full Text] [Related]
26. Pseudouridine and beta-aminoisobutyric acid excretion in urine: diagnostic and prognostic value.
Kvist E; Sjølin KE
Scand J Urol Nephrol; 1990; 24(4):283-5. PubMed ID: 2274752
[TBL] [Abstract][Full Text] [Related]
27. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
28. Non-Hodgkin's lymphomas: characteristics of long-term survivors following conservative treatment.
Straus DJ; Gaynor JJ; Leiberman PH; Filippa DA; Koziner B; Clarkson BD
Am J Med; 1987 Feb; 82(2):247-56. PubMed ID: 3812517
[TBL] [Abstract][Full Text] [Related]
29. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger.
Ng AK; Bernardo MP; Weller E; Backstrand KH; Silver B; Marcus KC; Tarbell NJ; Friedberg J; Canellos GP; Mauch PM
J Clin Oncol; 2002 Apr; 20(8):2101-8. PubMed ID: 11956271
[TBL] [Abstract][Full Text] [Related]
30. [Experience with results of treatment of non-Hodgkin's lymphoma].
Gurzó M; Dobos K; Bérczi M; Varga G; Kelényi G
Orv Hetil; 1992 May; 133(18):1091-7. PubMed ID: 1579348
[TBL] [Abstract][Full Text] [Related]
31. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic factors in patients with primary non-Hodgkin's lymphoma of the tonsil].
Gao Y; Li Y; Yuan Z; Zhao L; Liu X; Gu D; Qian T; Yu Z
Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):483-5. PubMed ID: 12485504
[TBL] [Abstract][Full Text] [Related]
33. [Statistical analysis of localized non-Hodgkin's lymphomas of the head and neck--multivariate analysis of prognostic factors and evaluation of therapeutic modalities].
Tomita T; Fujii M; Imanishi Y; Kanke M; Kanzaki J; Ohno Y; Tokumaru Y; Inuyama Y
Nihon Jibiinkoka Gakkai Kaiho; 1999 Jun; 102(6):809-17. PubMed ID: 10429435
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and prognostic analysis of 101 cases of primary gastrointestinal non-Hodgkin's lymphoma].
Song LN; Cen XN; Ou JP; Liang ZY; Qiu ZX; Wang WS; Xu WL; Li Y; Wang MJ; Dong YJ; Yin Y; Sun YH; Liu W; Wang Q; Wang LH; Wang Y; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):387-91. PubMed ID: 23628038
[TBL] [Abstract][Full Text] [Related]
35. [Non-Hodgkin's lymphoma in adults: a clinico-pathologic study of 169 cases].
Ding SL; Ko WS; Hwang WS
J Formos Med Assoc; 1990 Nov; 89(11):1017-22, 1015. PubMed ID: 1982122
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of the advantage of determination of urinary pseudouridine for the early detection of a malignant transformation process].
Senden D; Buchet JP; Lauwerys R
J Toxicol Clin Exp; 1990; 10(7-8):473-80. PubMed ID: 2135063
[TBL] [Abstract][Full Text] [Related]
37. So-called "Lennert's lymphoma": is it a clinicopathologic entity?
Kim H; Nathwani BN; Rappaport H
Cancer; 1980 Mar; 45(6):1379-99. PubMed ID: 6986978
[TBL] [Abstract][Full Text] [Related]
38. Morphologic classification of non-Hodgkin's lymphoma. I. Retrospective analysis using the Kiel classification.
Glimelius B; Sundström C
Acta Radiol Oncol; 1982; 21(5):289-97. PubMed ID: 6297247
[TBL] [Abstract][Full Text] [Related]
39. [Clinical analysis of 32 primary intestinal non-Hodgkin's lymphoma].
Bai CM; Yang T; Xü Y; Zhang W; Liu XL; Zhu YL; Chen SC; Shen T
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):142-4. PubMed ID: 16750023
[TBL] [Abstract][Full Text] [Related]
40. A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group.
Santini G; De Souza C; Aversa S; Patti C; Tedeschi L; Candela M; Olivieri A; Chisesi T; Rubagotti A; Centurioni R; Nardi V; Congiu M; Gennaro M; Truini M;
Braz J Med Biol Res; 2004 May; 37(5):719-28. PubMed ID: 15107935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
